G Samsioe
Overview
Explore the profile of G Samsioe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
141
Citations
422
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moberg L, Nilsson P, Samsioe G, Sallsten G, Barregard L, Engstrom G, et al.
Osteoporos Int
. 2017 Apr;
28(8):2401-2408.
PMID: 28432383
Introduction: Exposure to high levels of cadmium has been associated with an increased fracture risk. The aim was to investigate a perceived association between low levels of blood cadmium (B-Cd)...
2.
Samsioe G, Hruska J
Climacteric
. 2009 Dec;
13(1):34-44.
PMID: 20001563
Objective: To evaluate the influence of two ultra-low doses of oral continuous combined hormone therapy and placebo on metabolic parameters, and to assess safety endpoints and overall tolerability in healthy...
3.
Qader S, Shakir Y, Nyberg P, Samsioe G
Climacteric
. 2008 Nov;
11(6):475-82.
PMID: 18991074
Background: Metabolic syndrome (MS) is a common health problem in menopausal women. According to The Adult Treatment Panel (ATP) III, MS includes the combination of three or more of the...
4.
Gotmar A, Hammar M, Fredrikson M, Samsioe G, Nerbrand C, Lidfeldt J, et al.
Climacteric
. 2008 Jul;
11(4):304-14.
PMID: 18645696
Objectives: The aim of this study was to investigate possible associations between androgen concentrations in perimenopausal women and symptoms that may be associated with low androgen concentrations in the blood....
5.
Khatibi A, Agardh C, Shakir Y, Nerbrand C, Nyberg P, Lidfeldt J, et al.
Climacteric
. 2007 Sep;
10(5):386-92.
PMID: 17852141
Objective: The aim of this analysis was to delineate perceived associations between androgens and cardiovascular events in perimenopausal women. Design: A cross-sectional, population-based study of 6440 perimenopausal women aged 50-59...
6.
Devogelaer J, Brown J, Burckhardt P, Meunier P, Goemaere S, Lippuner K, et al.
Osteoporos Int
. 2007 May;
18(9):1211-8.
PMID: 17516022
Unlabelled: In a 5-year study involving 119 postmenopausal women, zoledronic acid 4 mg given once-yearly for 2, 3 or 5 years was well tolerated with no evidence of excessive bone...
7.
Samsioe G, Boschitsch E, Concin H, De Geyter C, Ehrenborg A, Heikkinen J, et al.
Climacteric
. 2006 Nov;
9(5):368-79.
PMID: 17080587
Objectives: To establish whether transdermal continuous hormone replacement therapy (HRT) with estrogen/progestogen provides adequate long-term endometrial protection in postmenopausal women over a period of 96 weeks. Methods: This multicenter, randomized,...
8.
Samsioe G
Climacteric
. 2005 Apr;
7(4):347-56.
PMID: 15799606
Hormone therapy (HT) in the climacteric has a number of beneficial effects including mitigation of climacteric symptoms and prevention of osteoporosis. Administration of HT via the transdermal route avoids hepatic...
9.
Elgan C, Dykes A, Samsioe G
Gynecol Endocrinol
. 2005 Feb;
19(4):169-77.
PMID: 15724798
Achievement of a high peak bone mass is considered a pivotal preventive strategy against future osteoporotic fractures. The ostensible interaction between physiology and lifestylefor the development of bone mass over...
10.
Shakir Y, Samsioe G, Nyberg P, Lidfeldt J, Nerbrand C
Climacteric
. 2005 Jan;
7(3):274-83.
PMID: 15669552
Objective: Cardiovascular diseases in women are multifactorial. Women carry different risk factors compared to men and these specific risk factors need to be delineated, particularly in relation to the hormonal...